Literature DB >> 22484630

Liposomal cytarabine in central nervous system disease of haematological malignancies: more effective but more toxic?

M Tormo Díaz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484630     DOI: 10.1007/s12094-012-0791-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  13 in total

1.  A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.

Authors:  Surasak Phuphanich; Bernard Maria; Rene Braeckman; Marc Chamberlain
Journal:  J Neurooncol       Date:  2006-08-29       Impact factor: 4.130

2.  Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

Authors:  Elias Jabbour; Susan O'Brien; Hagop Kantarjian; Guillermo Garcia-Manero; Alessandra Ferrajoli; Farhad Ravandi; Maria Cabanillas; Deborah A Thomas
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

Review 3.  Central nervous system disease in hematologic malignancies: historical perspective and practical applications.

Authors:  Ching-Hon Pui; Eckhard Thiel
Journal:  Semin Oncol       Date:  2009-08       Impact factor: 4.929

4.  Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

Authors:  M J Glantz; S LaFollette; K A Jaeckle; W Shapiro; L Swinnen; J R Rozental; S Phuphanich; L R Rogers; J C Gutheil; T Batchelor; D Lyter; M Chamberlain; B L Maria; C Schiffer; R Bashir; D Thomas; W Cowens; S B Howell
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

5.  Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement.

Authors:  A Navajas; A Lassaletta; A Morales; B López-Ibor; C Sábado; C Moscardó; E Mateos; J Molina; M Sagaseta; A Sastre
Journal:  Clin Transl Oncol       Date:  2012-04       Impact factor: 3.405

Review 6.  Cognitive sequelae of brain radiation in adults.

Authors:  Nadia N Laack; Paul D Brown
Journal:  Semin Oncol       Date:  2004-10       Impact factor: 4.929

7.  Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.

Authors:  L Bomgaars; J R Geyer; J Franklin; G Dahl; J Park; N J Winick; R Klenke; S L Berg; S M Blaney
Journal:  J Clin Oncol       Date:  2004-10-01       Impact factor: 44.544

8.  Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis.

Authors:  G A Omura; S Moffitt; W R Vogler; M M Salter
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

9.  The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

Authors:  A E Evans; E S Gilbert; R Zandstra
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

10.  Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.

Authors:  Hillard M Lazarus; Susan M Richards; Raj Chopra; Mark R Litzow; Alan K Burnett; Peter H Wiernik; Ian M Franklin; Martin S Tallman; Lucy Cook; Georgina Buck; I Jill Durrant; Jacob M Rowe; Anthony H Goldstone
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.